Results 51 to 60 of about 2,849 (199)

Reduced Neutrophil‐to‐Eosinophil Ratio in Chronic Dacryocystitis: A Hematological Clue to Allergic Pathogenesis

open access: yesJournal of Ophthalmology, Volume 2026, Issue 1, 2026.
Aim To examine complete blood count parameters for differences in chronic dacryocystitis compared to controls, exploring their potential link to a possible allergic‐inflammatory contribution in lacrimal surgery. Methods This retrospective study included 190 adults aged 18–83 years who underwent external dacryocystorhinostomy (DCR) for primary acquired ...
Gokhan Ozgur   +3 more
wiley   +1 more source

The Efficacy of Topical 0.03% Tacrolimus Dermatologic Ointment in Treatment of Vernal Keratoconjunctivitis

open access: yesLife and Science, 2021
Objective: To determine the efficacy of 0.03% Tacrolimus dermatologic ointment in the treatment of Vernal keratoconjunctivitis. Study Design: Cross-sectional.
Muhammad Adnan   +3 more
doaj   +1 more source

The Role of Decorin in the Ocular Surface: Structure, Function, and Therapeutic Potential

open access: yesProteoglycan Research, Volume 3, Issue 3, July 2025.
ABSTRACT The ocular surface, comprising the cornea, conjunctiva, and sclera, relies on a complex extracellular matrix (ECM) for structural support and functional integrity. Decorin (DCN), a small leucine‐rich proteoglycan, a key ECM component involved in collagen fibrillogenesis, growth factor modulation, and cellular regulation, is essential for ...
Kartik Goel   +5 more
wiley   +1 more source

Vernal keratoconjunctivitis treated with omalizumab: a case series

open access: yes, 2017
We report the cases of four children affected by Vernal keratoconjunctivitis (VKC) treated with Omalizumab with resolution of ocular signs and symptoms.
Di Fraia M   +7 more
core   +1 more source

EFFECTIVENESS OF STEROIDS VERSUS IMMUNOMODULATORS INTREATMENT OF VERNAL KERATO-CONJUNCTIVITIS. A STUDY AT ARMED FORCES INSTITUTE OF OPHTHALMOLOGY

open access: yesPakistan Armed Forces Medical Journal, 2021
Objective: To evaluate whether steroids or immunomodulator is a better mode of treatment in long term management of vernal keratoconjunctivitis. Study Design: A quasi experimental study.
Zahra Arsalan   +3 more
doaj  

Preservative-free diclofenac sodium 0.1% for vernal keratoconjunctivitis

open access: yes, 2003
The aim of this study is to evaluate the efficacy of prolonged treatment with preservative-free diclofenac sodium 0.1% eye drops in patients with vernal keratoconjunctivitis (VKC)
Cortes, Magdalena   +6 more
core   +1 more source

Fungal keratitis associated with vernal keratoconjunctivitis

open access: yes, 2003
Purpose: To report a case of fungal keratitis associated with vernal keratoconjunctivitis. Case Report: A 22-year-old man with a history of vernal keratoconjunctivitis since October 1999 developed a shield ulcer in the left eye in June 2000, which ...
Rao, Gullapalli N.   +2 more
core   +1 more source

Kingella kingae Keratitis in a Child with Underlying Vernal Keratoconjunctivitis [PDF]

open access: yes, 2017
Kingella kingae had rarely been reported as a causative organism for corneal ulcer and had not been described before in vernal keratoconjunctivitis (VKC).
Salim Nurul-Laila   +3 more
core   +3 more sources

Evidence on the Use of Topical Ciclosporin for Ocular Surface Disease: A Systematic Review and Meta‐Analysis

open access: yesClinical &Experimental Ophthalmology, Volume 53, Issue 5, Page 470-492, July 2025.
ABSTRACT Background To identify evidence on the use of topical CsA for ocular surface diseases (OSD). Methods A literature search was conducted following the preferred reporting items for systematic reviews and meta‐analyses (PRISMA) through June 2023 via Cochrane Central Registries, Clinical Trials Registry, Grey literature and citation searching ...
Ngozi C. Chidi‐Egboka   +10 more
wiley   +1 more source

Efficacy of mipragoside ophthalmic gel in vernal keratoconjunctivitis

open access: yes, 1996
To evaluate the efficacy of Mipragoside, a ganglioside derivative, in vernal keratoconjunctivitis we performed a controlled randomised clinical trial involving 24 patients (mean age 10+/-3.4 years, range 5-20 years).
Giuffrida S.   +6 more
core   +2 more sources

Home - About - Disclaimer - Privacy